Phase 4 Schizophrenia Trial, Recruiting NCT06634641 Sponsor: Centre Hospitalier Universitaire, Amiens Condition: Schizophrenia
Back to Schizophrenia

Phase 4 Schizophrenia Trial, Recruiting

NCT06634641
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and have been diagnosed with Parkinson's disease according to recognised medical guidelines (MDS 2015 criteria)
  • You are experiencing psychotic symptoms (such as hallucinations or delusions) that require treatment with a medication called Clozapine
  • Your blood test shows a normal white blood cell count and a normal level of a specific type of white blood cell called neutrophils before starting treatment
  • You are able to have regular blood tests — weekly for the first 18 weeks of treatment, then at least every 4 weeks after that, and for 4 weeks after stopping Clozapine
  • You are able to give your written agreement to take part in the trial after being fully informed about it
  • You are covered by a social security (health insurance) system

Who may not be able to join:

  • You have a medical reason that means you should not take Clozapine, as listed in the official medication guidelines
  • You have a known allergy or sensitivity to Clozapine or any of its ingredients
  • You are unable to have regular blood tests
  • You have a history of a serious drop in certain white blood cells (granulopenia or agranulocytosis), unless this was caused by chemotherapy
  • You have previously had a dangerous drop in white blood cells caused specifically by Clozapine
  • You are currently taking certain other medications known to strongly increase the risk of dangerously low white blood cells, or long-acting injectable antipsychotic medications
  • You have a condition where your bone marrow does not work properly
  • You have epilepsy that is not well controlled
  • Your psychotic symptoms are caused by alcohol, drugs, or poisoning, or you are in a coma
  • You have severe problems with circulation or significant suppression of the central nervous system (confirm with trial site)
  • You have serious kidney or heart problems (for example, inflammation of the heart called myocarditis)
  • You have active liver disease with symptoms such as nausea, loss of appetite, or yellowing of the skin; or a worsening liver condition; or liver failure
  • You have a condition called paralytic ileus, where the bowel stops working properly
  • You have another condition or are taking treatments that weaken your immune system
  • You are currently taking, or have taken in the last 5 years, medications that suppress or alter the immune system
  • You are currently taking, or have taken in the last 5 years, anti-epileptic medications
  • You have received chemotherapy in the last 5 years, or are currently receiving it
  • You have been diagnosed with cancer (any type) in the last 5 years, or are still being treated for it
  • You are living with HIV (Human Immunodeficiency Virus)
  • You have a known inherited condition that affects your immune system
  • You have a kidney condition called nephrotic syndrome
  • You have a condition where your gut loses large amounts of protein (protein-losing enteropathy)
  • You have a history of radiotherapy (radiation treatment)
  • You have been taking steroid medications (such as corticosteroids) for a long period of time
  • You scored 23 or below on a standard memory and thinking test called the MoCA, suggesting significant difficulties with thinking or memory
  • You are pregnant or breastfeeding
  • You are under legal guardianship or supervision, or you are not free to make your own decisions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 33 + 03 22 66 82 40

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Centre Hospitalier Universitaire, Amiens
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
1 September 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

change in serum IgG levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov